Page last updated: 2024-10-27

gabexate and Tricuspid Incompetence

gabexate has been researched along with Tricuspid Incompetence in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"To investigate disseminated intravascular coagulation (DIC) after valve replacement, we studied DIC score in 80 patients with combined cardiac valvular disease."1.28[Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation]. ( Abe, T; Hagiwara, K; Igari, T; Iwaya, F; Midorikawa, H; Sato, Y; Satokawa, H; Takase, S; Tanji, M; Watanabe, M, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satokawa, H1
Iwaya, F1
Igari, T1
Abe, T1
Hagiwara, K1
Tanji, M1
Watanabe, M1
Midorikawa, H1
Sato, Y1
Takase, S1

Other Studies

1 other study available for gabexate and Tricuspid Incompetence

ArticleYear
[Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
    Kyobu geka. The Japanese journal of thoracic surgery, 1990, Volume: 43, Issue:4

    Topics: Adult; Aged; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; H

1990